An MIT-developed device with the appearance of a Wi-Fi router uses a neural network to discern the presence and severity of one of the fastest-growing neurological diseases in the world.
A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Have a question about numerical differential equations? Odds are this CSAIL research affiliate has already addressed it.
Researchers create a mathematical framework to examine the genome and detect signatures of natural selection, deciphering the evolutionary past and future of non-coding DNA.
Novel lysin Abp013 has shown promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae.
Study results also show that pancreatic tumor cells can be forced into a more susceptible state by changing their environment.
A deep learning model rapidly predicts the 3D shapes of drug-like molecules, which could accelerate the process of discovering new medicines.
A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
“A Shot in the Arm,” a new book from Professor Yossi Sheffi, reveals lessons about overcoming global threats.